[1]周 欣,冯诚怿,耿雯雯,等.基于CiteSpace的血液透析相关感染文献的可视化分析[J].医学信息,2023,36(15):51-56.[doi:10.3969/j.issn.1006-1959.2023.15.009]
　ZHOU Xin,FENG Cheng-yi,GENG Wen-wen,et al.Visual Analysis of Hemodialysis-related Infection Literature Based on CiteSpace[J].Journal of Medical Information,2023,36(15):51-56.[doi:10.3969/j.issn.1006-1959.2023.15.009]
点击复制

基于CiteSpace的血液透析相关感染文献的可视化分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年15期
页码:
51-56
栏目:
医学数据科学
出版日期:
2023-08-01

文章信息/Info

Title:
Visual Analysis of Hemodialysis-related Infection Literature Based on CiteSpace
文章编号:
1006-1959（2023）15-0051-06
作者:
周 欣; 冯诚怿; 耿雯雯; 等
（常州市第一人民医院肾内科1，感染管理办公室2，江苏 常州 213003）
Author(s):
ZHOU Xin; FENG Cheng-yi; GENG Wen-wen; et al.
(Department of Nephrology1,Infection Management Office2,the First People’s Hospital of Changzhou,Changzhou 213003,Jiangsu,China)
关键词:
血液透析; 丙型病毒性肝炎; 终末期肾脏病; CiteSpace; 可视化分析
Keywords:
emodialysis; Hepatitis C virus; End-stage renal disease; CiteSpace; Visual analysis
分类号:
R495.5
DOI:
10.3969/j.issn.1006-1959.2023.15.009
文献标志码:
A
摘要:
目的 基于CiteSpace对2012-2021年血液透析相关感染文献进行可视化图谱分析，分析其研究现状、热点及变化趋势。方法 以hemodialysis、infection为主题，检索Web of Science核心数据库相关文献，检索时间设置为2012年1月1日-2021年12月30日。应用CiteSpace 5.8.R3软件对作者、机构、国家、关键词、分类等进行可视化分析。结果 共纳入3716篇相关文献。从发文趋势可知，血液透析相关感染一直为研究重点，近10年年发文量总体呈增长趋势，且年发文量维持在300篇以上。从国家与机构可知，排名前3的国家分别是美国、中国、日本，且美国中介中心性最高，而研究机构中以多伦多大学发文量最多。Fabrizio Fabrizi是发文量最多的作者，其主要研究方向为血液透析患者丙型病毒性肝炎感染。对关键词进行可视化分析，血液透析、感染、终末期肾病、死亡率、危险因素、预防、血管通路为高频关键词。关键词突现中肝炎、抗病毒治疗可能为未来研究重点。科目分类中社会科学、机械工程中心性较高。结论 血液透析相关感染近几年发文量升高，丙型病毒性肝炎感染一直为研究热点，抗病毒治疗的研究未来仍具有发展前景。
Abstract:
Objective To analyze the literature on hemodialysis-related infections from 2012 to 2021 based on CiteSpace, and to analyze the research status, hotspots and trends.Methods With the theme of hemodialysis and infection, the relevant literatures in the core database of Web of Science were retrieved. The retrieval time was set from January 1, 2012 to December 30, 2021. CiteSpace 5.8.R3 software was used to visually analyze authors, institutions, countries, keywords, classifications, etc.Results A total of 3716 related literatures were included. From the analysis of the trend of publications, hemodialysis-related infections had always been the focus of research. In the past 10 years, the annual number of publications had generally shown an increasing trend, and the annual number of publications had remained at more than 300. From the perspective of countries and institutions, the top three countries were the United States, China and Japan, and the United States had the highest degree of intermediary centrality, while the University of Toronto had the largest number of publications among research institutions. Fabrizio Fabrizi was the author with the largest number of publications, the main research direction was hepatitis C virus infection in hemodialysis patients. Visual analysis of keywords showed that hemodialysis, infection, end-stage renal disease, mortality, risk factors, prevention, and vascular access were high-frequency keywords. Keywords burst showed that hepatitis and antiviral therapy might be the focus of future research. In the classification of subjects, the centrality of social science and mechanical engineering was higher.Conclusion The annual number of published papers on hemodialysis-related infections has increased in recent years. Hepatitis C infection has always been a research hotspot, and the research on antiviral therapy may still have development prospects.

参考文献/References:

[1]Collins AJ,Foley RN,Chavers B,et al.’United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States[J].Am J Kidney Dis,2012,59(1 Suppl 1):A7,e1-420.[2]Fan PY,Schwab SJ.Vascular access: concepts for the 1990s[J].J Am Soc Nephrol,1992,3(1):1-11.[3]Chen C.Searching for intellectual turning points: progressive knowledge domain visualization[J].Proc Natl Acad Sci U S A,2004,101 Suppl 1(Suppl 1):5303-5310.[4]Chen C,Song M.Visualizing a field of research: A methodology of systematic scientometric reviews[J].PLoS One,2019,14(10):e0223994.[5]Selvaskandan H,Hull KL,Adenwalla S,et al.Risk factors associated with COVID-19 severity among patients on maintenance haemodialysis: a retrospective multicentre cross-sectional study in the UK[J].BMJ Open,2022,12(5):e054869.[6]Weiss S,Bhat P,Del Pilar Fernandez M,et al.COVID-19 Infection in ESKD: Findings from a Prospective Disease Surveillance Program at Dialysis Facilities in New York City and Long Island[J].J Am Soc Nephrol,2020,31(11):2517-2521.[7]Alberici F,Delbarba E,Manenti C,et al.A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection[J].Kidney Int,2020,98(1):20-26.[8]Salzer WL.Peritoneal dialysis-related peritonitis: challenges and solutions[J].Int J Nephrol Renovasc Dis,2018,11:173-186.[9]Lee JJ,Lin MY,Chang JS,et al.Hepatitis C virus infection increases risk of developing end-stage renal disease using competing risk analysis[J].PLoS One,2014,9(6):e100790.[10]Satapathy SK,Lingisetty CS,Williams S.Higher prevalence of chronic kidney disease and shorter renal survival in patients with chronic hepatitis C virus infection[J].Hepatol Int,2012,6(1):369-378.[11]Kikuchi K.Treatment of Hepatitis C Virus Infection in Dialysis Patients[J].Contrib Nephrol,2018,196:119-122.[12]Loustaud-Ratti V,Carrier P,Vong C,et al.Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir[J].Hepatology,2014,59(6):2426.[13]Carrat F,Fontaine H,Dorival C,et al.Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study[J].Lancet,2019,393(10179):1453-1464.[14]Strohbehn IA,Seethapathy R,Lee M,et al.Curative Therapies for Hepatitis C Virus Infection in Patients with Kidney Disease[J].Kidney360,2021,2(8):1316-1325.[15]Gane E,Lawitz E,Pugatch D,et al.Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment[J].N Engl J Med,2017,377(15):1448-1455.[16]Chuang WL,Hu TH,Buggisch P,et al.Ledipasvir/Sofosbuvir for 8,12,or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal Disease[J].Am J Gastroenterol,2021,116(9):1924-1928.[17]Borgia SM,Dearden J,Yoshida EM,et al.Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis[J].J Hepatol,2019,71(4):660-665.[18]Roth D,Bloom RD,Molnar MZ,et al.KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention,Diagnosis,Evaluation,and Treatment of Hepatitis C[J].Am J Kidney Dis,2020,75(5):665-683.[19]Dalrymple LS,Mu Y,Romano PS,et al.Outcomes of infection-related hospitalization in Medicare beneficiaries receiving in-center hemodialysis[J].Am J Kidney Dis,2015,65(5):754-762.[20]Delistefani F,Wallbach M,Müller GA,et al.Risk factors for catheter-related infections in patients receiving permanent dialysis catheter[J].BMC Nephrol,2019,20(1):199.

相似文献/References:

[1]肖一红.组合型人工肾技术预防血液透析中低血压的效果观察[J].医学信息,2018,31(03):185.[doi:10.3969/j.issn.1006-1959.2018.03.070]
　XIAO Yi-hong.Effect of Combined Artificial Renal Technique in Preventing Hypotension in Hemodialysis[J].Journal of Medical Information,2018,31(15):185.[doi:10.3969/j.issn.1006-1959.2018.03.070]
[2]邹 鑫,刘秀娟,余燕燕.血液透析对MHD患者血清FGF-23水平与 钙磷代谢的影响[J].医学信息,2018,31(09):119.[doi:10.3969/j.issn.1006-1959.2018.09.036]
　ZOU Xin,LIU Xiu-juan,YU Yan-yan.Effect of Hemodialysis on Serum FGF-23 Level and Calcium and Phosphorus Metabolism in MHD Patients[J].Journal of Medical Information,2018,31(15):119.[doi:10.3969/j.issn.1006-1959.2018.09.036]
[3]王允彦.西那卡塞对维持性血液透析继发性甲状旁腺功能亢进患者FGF-23的影响[J].医学信息,2018,31(13):88.[doi:10.3969/j.issn.1006-1959.2018.13.025]
　WANG Yun-yan.Effect of Cinacalcet on FGF-23 in Patients with Secondary Hyperparathyroidism during Maintenance Hemodialysis[J].Journal of Medical Information,2018,31(15):88.[doi:10.3969/j.issn.1006-1959.2018.13.025]
[4]蒋红利,刘 华,史珂慧,等.陕西省县级医院透析室建设项目培训效果评价[J].医学信息,2018,31(19):120.[doi:10.3969/j.issn.1006-1959.2018.19.036]
　JIANG Hong-li,LIU Hua,SHI Ke-hui,et al.Evaluation on Training Effect of Dialysis Room Construction Project in County Hospitals in Shaanxi Province[J].Journal of Medical Information,2018,31(15):120.[doi:10.3969/j.issn.1006-1959.2018.19.036]
[5]方海东,李 荣.血液透析滤过联合血液透析治疗慢性肾功能衰竭的效果观察[J].医学信息,2019,32(02):129.[doi:10.3969/j.issn.1006-1959.2019.02.037]
　FANG Hai-dong,LI Rong.Effect of Hemodiafiltration Combined with Hemodialysis on Chronic Renal Failure[J].Journal of Medical Information,2019,32(15):129.[doi:10.3969/j.issn.1006-1959.2019.02.037]
[6]张民霞.血液灌流联合血液透析治疗肾功能衰竭难治性高血压的效果[J].医学信息,2019,32(15):109.[doi:10.3969/j.issn.1006-1959.2019.15.035]
　ZHANG Min-xia.Effect of Hemoperfusion Combined with Hemodialysis on Refractory Hypertension with Renal Failure[J].Journal of Medical Information,2019,32(15):109.[doi:10.3969/j.issn.1006-1959.2019.15.035]
[7]谢 华,周毅峰,甘晓庆,等.血液透析专用中心静脉导管封管液的研究[J].医学信息,2019,32(18):48.[doi:10.3969/j.issn.1006-1959.2019.18.016]
　XIE Hua,ZHOU Yi-feng,GAN Xiao-qing,et al.Research on Central Venous Catheter Sealing Fluid for Hemodialysis[J].Journal of Medical Information,2019,32(15):48.[doi:10.3969/j.issn.1006-1959.2019.18.016]
[8]喻学娜.协同护理对终末期肾脏病血液透析患者自我护理能力及治疗依从性的影响[J].医学信息,2019,32(20):183.[doi:10.3969/j.issn.1006-1959.2019.20.059]
　YU Xue-na.Effect of Collaborative Nursing on Self-care Ability and Treatment Compliance of Hemodialysis Patients with End-stage Renal Disease[J].Journal of Medical Information,2019,32(15):183.[doi:10.3969/j.issn.1006-1959.2019.20.059]
[9]魏昌林.血液透析联合血液灌流在终末期肾病患者治疗中的应用[J].医学信息,2019,32(13):109.[doi:10.3969/j.issn.1006-1959.2019.13.032]
　WEI Chang-lin.Application of Hemodialysis Combined with Blood Perfusion in the Treatment of Patients with End-stage Renal Disease[J].Journal of Medical Information,2019,32(15):109.[doi:10.3969/j.issn.1006-1959.2019.13.032]
[10]钟瑜辉.血液透析联合血液灌流治疗尿毒症的效果[J].医学信息,2019,32(21):108.[doi:10.3969/j.issn.1006-1959.2019.21.034]
　ZHONG Yu-hui.Effect of Hemodialysis Combined with Blood Perfusion on Uremia[J].Journal of Medical Information,2019,32(15):108.[doi:10.3969/j.issn.1006-1959.2019.21.034]

更新日期/Last Update: 1900-01-01